Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Zellweger spectrum disorder (ZSD) is a heterogeneous group of diseases with high morbidity and mortality caused by failure to assemble normal peroxisomes. There is no therapy for ZSD, but management is supportive. Nevertheless, one-half of the patients have a phenotype milder than classic Zellweger syndrome and exhibit a progressive disease course. Thus, patients would benefit if therapies became available and were instituted early. Recent reports indicate several interventions that result in partial peroxisome recovery in ZSD fibroblasts. To identify drugs that recover peroxisome functions, we expressed a GFP-peroxisome targeting signal 1 reporter in fibroblasts containing the common disease allele, PEX1-p.Gly843Asp. The GFP reporter remained cytosolic at baseline, and improvement in peroxisome functions was detected by the redistribution of the GFP reporter from the cytosol to the peroxisome. We established a high-content screening assay based on this phenotype assay and evaluated 2,080 small molecules. The cells were cultured in chemical for 2 days and then, were fixed and imaged by epifluorescent microscopy on a high-content imaging platform. We identified four compounds that partially recover matrix protein import, and we confirmed three using independent assays. Our results suggest that PEX1-p.G843D is a misfolded protein amenable to chaperone therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hubbard, W. C., Moser, A. B., Liu, A. C., Jones, R. O., Steinberg, S. J., Lorey, F., Panny, S. R., Vogt Jr., R. F., Macaya, D., & Turgeon, C. T. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.03.010 · Cited by 177 · cited 1×
“The anticipated inclusion of peroxisomal disorders in expanded newborn screening programs presents a major challenge to uncover methods to delay the onset or progression of these disorders (35).”
BackgroundSelf-citationBenjamin, E. R., Flanagan, J. J., Schilling, A., Chang, H. H., Agarwal, L., Katz, E., Wu, X., Pine, C., Wustman, B., Desnick, R. J., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1077-0 · Cited by 173 · cited 1×
“Examples of drugs developed as pharmacologic chaperones include enzyme substrates or inhibitors, such as the iminosugar 1-deoxygalactonojirimycin (a reversible, competitive inhibitor of α-Gal A in Fabry disease) (21) and antagonists of the vasopressin V2 receptor in nephrogenic diabetes insipidus (22).”
BackgroundMycoplasma detection by PCR analysis
Hopert, A., Uphoff, C. C., Wirth, M., Hauser, H., & Drexler, H. G. (1993) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02634350 · Cited by 29 · cited 1×
“PCR amplification detected no mycoplasma genomes (37).”
Molecular Mechanism of a Temperature-Sensitive Phenotype in Peroxisomal Biogenesis Disorder
Hashimoto, K., Kato, Z., Nagase, T., Shimozawa, N., Kuwata, K., Omoya, K., Li, A., Matsukuma, E., Yamamoto, Y., Ohnishi, H., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000169984.89199.69 · Cited by 16
Cited by
Using Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“AGPS, PhyH, and thiolase are imported into the peroxisome and undergo tubulin, loading control.”
BackgroundMethodInfluentialSelf-citationBraverman, N. E., Raymond, G. V., Rizzo, W. B., Moser, A. B., Wilkinson, M. E., Stone, E. M., Steinberg, S. J., Wangler, M. F., Rush, E. T., Hacia, J. G., et al. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.12.009 · Cited by 281
Self-citationThe Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder
Hiebler, S., Masuda, T., Hacia, J. G., Moser, A. B., Faust, P. L., Liu, A., Chowdhury, N., Huang, N., Lauer, A., Bennett, J., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.01.008 · Cited by 60
Self-citationWang, S., Yang, H., Fu, Y., Teng, X., Wang, C., & Xu, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7982344 · Cited by 19
“In addition, some ongoing clinical trials have identi fi ed several compounds that can stimulate peroxisomal biogenesis and function in vitro [175 – 179].”
Metadata
- Authors
- Zhang, R., Chen, L., Jiralerspong, S., Snowden, A., Steinberg, S., & Braverman, N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-03-08
- Volume
- 107
- Issue
- 12
- Pages
- 5569-5574
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1992127013
- Cited by
- 59
- References
- 4
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.